The goal of this study is to build a clinical research network that can support treatment and prevention studies, and to better understand the biomarkers of FTD.
The purpose of the study is to develop ways for understanding brain changes effecting memory and thinking that occur with age.
The goal of the study is to examine olfactory function (or the sense of smell) in healthy individuals and in preclinical and clinical subjects with Alzheimer's Disease, Dementia with Lewy Bodies, or Frontotemporal Dementias.
The purpose of this research study is to look at brain connectivity in a variety of people with memory problems, including people with complaints about their memory and people diagnosed with a neurodegenerative disease, including Alzheimer’s disease (AD), fronto-temporal dementia (FTD), and mild cognitive impairment (MCI).
The purpose of this study is to determine the presence of the protein Tau in the brain in a variety of populations, ranging from healthy adults to those diagnosed with a neurodegenerative disease.
This study will use PET neuroimaging to determine the amount of tau protein in the brain and to explore the relationship between presence of tau and clinical course of Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
The goal of this study is to determine whether there is a preclinical FTD stage where those at risk for FTD have changes in their brain structure but no symptoms of FTD.
The purpose of the study is to see if there are brainwave abnormalities in the brains of people with Alzheimer’s Disease and determine whether there is a distinct brainwave signature for Alzheimer’s Disease.
The goal of the study is to examine brain changes in gene carriers who do not have symptoms of FTD, and find factors that predict disease course in people who already have, or may later be diagnosed with FTD.
The goal of this study is to better understand how the proteins tau and amyloid in the brain relate to PSP and CBD symptoms.